Cargando…

Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) is characterized by a metabolic shift from fat to carbohydrates and failure to increase myocardial glucose uptake in response to workload increments. We verified whether this pattern is influenced by an abnormal glucose tolerance (AGT). In 10 patients with DCM, 5 with no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tricò, Domenico, Baldi, Simona, Frascerra, Silvia, Venturi, Elena, Marraccini, Paolo, Neglia, Danilo, Natali, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699228/ https://www.ncbi.nlm.nih.gov/pubmed/26798650 http://dx.doi.org/10.1155/2016/3906425

Ejemplares similares

A Protein/Lipid Preload Attenuates Glucose-Induced Endothelial Dysfunction in Individuals with Abnormal Glucose Tolerance
por: Tricò, Domenico, et al.
Publicado: (2020)

Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications
por: Nesti, Lorenzo, et al.
Publicado: (2019)

Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function
por: Nesti, Lorenzo, et al.
Publicado: (2022)

Myocardial remodelling and recovery in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Ablation of palladin in adult heart causes dilated cardiomyopathy associated with intercalated disc abnormalities
por: Mastrototaro, Giuseppina, et al.
Publicado: (2023)

Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial
por: Nesti, Lorenzo, et al.
Publicado: (2022)

Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia
por: Heitmeier, Monique R., et al.
Publicado: (2018)

Prevalence of increased myocardial extracellular volume fraction in dilated cardiomyopathy
por: Lundin, Magnus, et al.
Publicado: (2013)

A novel method for interpreting survival analysis data: description and test on three major clinical trials on cardiovascular prevention
por: Mengozzi, Alessandro, et al.
Publicado: (2020)

Effects of Low-Carbohydrate versus Mediterranean Diets on Weight Loss, Glucose Metabolism, Insulin Kinetics and β-Cell Function in Morbidly Obese Individuals
por: Tricò, Domenico, et al.
Publicado: (2021)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

Dysregulation of Iron Metabolism-Linked Genes at Myocardial Tissue and Cell Levels in Dilated Cardiomyopathy
por: Massaiu, Ilaria, et al.
Publicado: (2023)

Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies
por: Brayson, Daniel, et al.
Publicado: (2019)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Triglyceride-glucose index predicts outcome in patients with chronic coronary syndrome independently of other risk factors and myocardial ischaemia
por: Neglia, Danilo, et al.
Publicado: (2021)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
por: Natali, Andrea, et al.
Publicado: (2021)

Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
por: Nesti, Lorenzo, et al.
Publicado: (2021)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
por: Fanaie, Fariba, et al.
Publicado: (2011)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy
por: Lionetti, Vincenzo, et al.
Publicado: (2014)

Myocardial deformation pattern in left ventricular non-compaction: Comparison with dilated cardiomyopathy
por: Huttin, Olivier, et al.
Publicado: (2014)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
por: Han, Yuchi, et al.
Publicado: (2009)

Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain
por: Ochs, Andreas, et al.
Publicado: (2021)

Myocardial recovery evaluation from ventricular assist device in patients with dilated cardiomyopathy
por: Gyoten, Takayuki, et al.
Publicado: (2022)

Risk factors for atrial fibrillation in dogs with dilated cardiomyopathy
por: Guglielmini, Carlo, et al.
Publicado: (2023)

Analysis of the role of glucose metabolism-related genes in dilated cardiomyopathy based on bioinformatics
por: Chen, Keping, et al.
Publicado: (2023)

Mitochondrial Function and Dysfunction in Dilated Cardiomyopathy
por: Ramaccini, Daniela, et al.
Publicado: (2021)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
por: Chiti, Enrica, et al.
Publicado: (2021)

Association Between Echocardiographic Non-invasive Myocardial Work Indices and Myocardial Fibrosis in Patients With Dilated Cardiomyopathy
por: Cui, Cunying, et al.
Publicado: (2021)

The electrocardiogram in non-ischaemic-dilated cardiomyopathy
por: Crescenzi, Cinzia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lfjpe2fb700i53ad2se2il0fin